Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: REPL stock price vs PLAY: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at PLAY's multiple
Needs Revenue / share.
Implied fair value · at REPL's multiple
Needs REPL P/S.
Snapshot Sep 8, 2026, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Higher is better
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: REPL FY 2026 (ended Mar 31, 2026) · PLAY FY 2026 (ended Feb 3, 2026). Fiscal years are not aligned.
Trendline
Eight period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
Market cap plus debt, less cash.
Capital structure 94% equity / 6% debt
Capital structure 16% equity / 84% debt · EV / Revenue 0.88x · EV / EBITDA 5.48x
PLAY carries the larger enterprise value at $1.85B against $1.21B.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
REPLIMUNE GROUP, INC. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Dave & Buster’s Entertainment, Inc. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
0.50x
17.10x
Net debt / EBITDA
Leverage against operating earnings
0.60x
4.57x
Cash and equivalents
Liquid reserves on the balance sheet
$268.89M
$16.60M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
AMGEN INC
REPL vs AMGN
INCYTE CORP
REPL vs INCY
Blueprint Medicines Corp
REPL vs BPMC
Adaptive Biotechnologies Corp
REPL vs ADPT
BRINKER INTERNATIONAL, INC
REPL vs EAT
Dine Brands Global, Inc.
REPL vs DIN
CHIPOTLE MEXICAN GRILL INC
REPL vs CMG
Bloomin' Brands, Inc.
REPL vs BLMN
DARDEN RESTAURANTS INC
REPL vs DRI
Texas Roadhouse, Inc.
REPL vs TXRH
$83.31M
$1.56B
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
